Lana Medical Company (TADAWUL:9587)
Saudi Arabia · Delayed Price · Currency is SAR 2.990
+0.110 (3.82%)
Aug 13, 2026, 2:07 PM AST
Lana Medical Company Ratios and Metrics
Market cap in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 160 | 132 | 160 | 115 | - | - | |
Market Cap Growth | -12.94% | -17.57% | 38.75% | - | - | - |
Enterprise Value | 184 | 141 | 163 | 120 | - | - |
Last Close Price | 2.96 | 2.44 | 2.96 | 2.13 | - | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 59.28 | 48.87 | 12.83 | - | - | - |
PS Ratio | 1.73 | 1.43 | 1.90 | 2.37 | - | - |
PB Ratio | 2.45 | 2.02 | 2.62 | 2.36 | - | - |
P/TBV Ratio | 2.46 | 2.03 | 2.63 | 2.37 | - | - |
P/OCF Ratio | - | - | 406.51 | 112.52 | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.00 | 1.53 | 1.94 | 2.47 | - | - |
EV/EBITDA Ratio | 16.91 | 13.71 | 14.60 | 107.83 | - | - |
EV/EBIT Ratio | 35.48 | 23.67 | 19.25 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.45 | 0.45 | 0.25 | 0.23 | 0.16 | 0.21 |
Debt / EBITDA Ratio | 2.49 | 2.49 | 1.29 | 7.11 | 0.94 | 1.04 |
Debt / FCF Ratio | - | - | - | - | 15.15 | - |
Net Debt / Equity Ratio | 0.38 | 0.38 | 0.15 | -0.15 | 0.09 | 0.13 |
Net Debt / EBITDA Ratio | 2.39 | 2.39 | 0.81 | -6.67 | 0.56 | 0.65 |
Net Debt / FCF Ratio | -2.37 | -2.37 | -2.43 | 3.06 | 8.50 | -0.43 |
Asset Turnover | 0.79 | 0.79 | 0.94 | 0.70 | 0.68 | - |
Inventory Turnover | 9.09 | 9.09 | 15.44 | 8.34 | 5.37 | - |
Quick Ratio | 1.11 | 1.11 | 1.47 | 2.38 | 3.34 | 4.52 |
Current Ratio | 1.58 | 1.58 | 1.87 | 3.03 | 4.16 | 5.39 |
Return on Equity (ROE) | 4.28% | 4.28% | 22.70% | -4.00% | 12.34% | - |
Return on Assets (ROA) | 3.16% | 3.16% | 5.92% | -0.33% | 6.77% | - |
Return on Invested Capital (ROIC) | 4.77% | 5.36% | 13.93% | -0.79% | 11.00% | 13.24% |
Return on Capital Employed (ROCE) | 7.50% | 7.50% | 11.80% | -0.60% | 12.40% | 14.80% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 1.69% | 2.05% | 7.80% | -1.67% | - | - |
FCF Yield | -6.49% | -7.87% | -2.33% | -2.11% | - | - |
Dividend Yield | 1.00% | 1.23% | - | - | - | - |
Buyback Yield / Dilution | - | - | -18.38% | -1.37% | -37.11% | - |
Total Shareholder Return | 1.00% | 1.23% | -18.38% | -1.37% | -37.11% | - |